摘要 |
Disclosed is a family of novel protein constructs, useful as drugs and for other purposes, termed "adzymes," comprising an address moiety and a catalytic domain. A preferred adzyme is one having a catalytic domain based on mesotrypsin (including functional fragments, derivatives, variants, homologs, and/or stabilized mutations thereof). Another preferred adzyme is one having a targeting moiety based on a protein scaffold, such a protein having an immunoglobulin-like fold. |
申请人 |
COMPOUND THERAPEUTICS, INC.;AFEYAN, NOUBAR, B.;LEE, FRANK, D.;WONG, GORDON, G.;DAS GUPTA, RUCHIRA;BAYNES, BRIAN;CAMPHAUSEN, RAY |
发明人 |
AFEYAN, NOUBAR, B.;LEE, FRANK, D.;DAS GUPTA, RUCHIRA;BAYNES, BRIAN;CAMPHAUSEN, RAY |